Medovert

Cinnarizine and Dimenhydrinate, the active ingredients in Medovert, are antihistamines presented as an oral tablet for oral use. They are employed to alleviate motion‑related nausea, vertigo and other vestibular disturbances in adults and children as directed by a healthcare professional.

GNH USA supplies Medovert as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Medovert, containing cinnarizine and dimenhydrinate, is used to manage vestibular and histamine‑mediated conditions.

Motion sickness: reduces nausea and vomiting associated with travel. Vertigo: alleviates dizziness caused by vestibular dysfunction. Nausea: controls nausea from various causes. Vomiting: helps suppress vomiting episodes.

Common Side Effects: - Drowsiness: feeling unusually sleepy or fatigued. - Dry mouth: reduced salivation leading to a parched sensation. - Headache: mild to moderate head pain. - Gastrointestinal discomfort: nausea, abdominal pain or mild diarrhea.

Serious or Rare Side Effects: - Extrapyramidal symptoms: involuntary muscle movements or tremor. - Severe allergic reactions: rash, swelling, or difficulty breathing. - Hepatic dysfunction: signs of liver injury such as jaundice. - Cardiac arrhythmia: irregular heart rhythm. - Blood dyscrasias: abnormal blood counts. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.

Before using Medovert, consider the following precautions.

Pregnancy: consult a healthcare provider before use. Elderly: monitor for increased sedation and falls. Driving: avoid operating machinery until individual response is known. Medical conditions: use cautiously in hepatic or renal impairment. Drug interactions: review all concomitant medications. Store at ambient temperature: keep in the original container, protect from moisture and light.

Medovert may interact with several medicines; review the following categories.

Major Interactions (Avoid): - Alcohol: additive sedation and impaired coordination. - CNS depressants: increased drowsiness and respiratory depression. - Anticholinergic drugs: heightened anticholinergic effects such as dry mouth and blurred vision.

Moderate Interactions (Monitor Closely): - Antihypertensives: possible additive hypotensive effect. - Antidepressants (SSRIs): monitor for serotonin syndrome symptoms. - Other antihistamines: increased anticholinergic load and sedation.